Butt Ahmad, Bach Horacio
Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Faculty of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, BC, Canada.
Nanomedicine (Lond). 2025 Jan;20(2):167-182. doi: 10.1080/17435889.2024.2439776. Epub 2024 Dec 11.
Integrating nanotechnologies in diagnostic imaging presents a promising step forward compared to traditional methods, which carry certain limitations. Conventional imaging routes, such as X-ray/computed tomography and magnetic resonance imaging, derive significant advantages from nanoparticles (NPs), which allow researchers and clinicians to overcome some of the limitations of traditional imaging agents. In this literature review, we explore recent advancements in nanomaterials being applied in conventional diagnostic imaging techniques by exploring relevant reviews and original research papers (e.g. experimental models and theoretical model studies) in the literature. Collectively, there are numerous nanomaterials currently being examined for use in conventional imaging modalities, and each imaging technique has unique NPs with properties that can be manipulated to answer an array of clinical questions specific to that imaging modality. There are still challenges to consider, including getting regulatory approval for clinical research and routine use about long-term biocompatibility, which collectively emphasize the need for continued research to facilitate the integration of nanotechnology into routine clinical practice. Most importantly, there is a continued need for strong, collaborative efforts between researchers, biomedical engineers, clinicians, and industry stakeholders, which are necessary to bridge the persistent gap between translational ideas and implementation in clinical settings.
与具有一定局限性的传统方法相比,将纳米技术整合到诊断成像中是向前迈出的充满希望的一步。传统的成像途径,如X射线/计算机断层扫描和磁共振成像,从纳米颗粒(NPs)中获得了显著优势,这使研究人员和临床医生能够克服传统成像剂的一些局限性。在这篇文献综述中,我们通过探索文献中的相关综述和原创研究论文(如实验模型和理论模型研究),来探讨应用于传统诊断成像技术的纳米材料的最新进展。总体而言,目前有许多纳米材料正在接受用于传统成像模式的研究,并且每种成像技术都有独特的纳米颗粒,其特性可以被操控以回答该成像模式特有的一系列临床问题。仍有一些挑战需要考虑,包括获得临床研究的监管批准以及关于长期生物相容性的常规使用,这些共同强调了持续研究以促进纳米技术融入常规临床实践的必要性。最重要的是,研究人员、生物医学工程师、临床医生和行业利益相关者之间持续需要强有力的协作努力,这对于弥合临床环境中转化理念与实施之间持续存在的差距是必要的。